[1] Chen W, Zheng R, Baade PD, et al.Cancer statistics in China, 2015[J]. CA Cancer J Clin,2016,66(2):115-132.
[2] Iqbal J, Ginsburg O, Rochon PA, et al.Differences in breast cancer stage at diagnosis and cancer-specific survival by race and ethnicity in the United States[J]. JAMA,2015,313(2):165-173.
[3] Fisher B, Gunduz N, Coyle J, et al.Presence of a growth-stimulating factor in serum following primary tumor removal in mice[J]. Cancer Res,1989,49(8):1996-2001.
[4] Hellman S, Weichselbaum RR.Oligometastases[J]. J Clin Oncol,1995,13(1):8-10.
[5] Weichselbaum RR, Hellman S.Oligometastases revisited[J]. Nat Rev Clin Oncol,2011,8(6):378-382.
[6] Milano MT, Katz AW, Schell MC, et al.Descriptive analy-sis of oligometastatic lesions treated with curative-intent stereotactic body radiotherapy[J]. Int J Radiat Oncol Biol Phys,2008,72(5):1516-1522.
[7] Khan SA, Stewart AK, Morrow M.Does aggressive local therapy improve survival in metastatic breast cancer?[J]. Surgery,2002,132(4):620-627.
[8] Babiera GV, Rao R, Feng L, et al.Effect of primary tumor extirpation in breast cancer patients who present with stageⅣ disease and an intact primary tumor[J]. Ann Surg Oncol,2006,13(6):776-782.
[9] Gnerlich J, Jeffe DB, Deshpande AD, et al.Surgical removal of the primary tumor increases overall survival in patients with metastatic breast cancer: analysis of the 1988-2003 SEER data[J]. Ann Surg Oncol,2007,14(8):2187-2194.
[10] Cady B, Nathan NR, Michaelson JS, et al.Matched pair analyses of stage IV breast cancer with or without resection of primary breast site[J]. Ann Surg Oncol,2008,15(12):3384-3395.
[11] Ruiterkamp J, Ernst MF, van de Poll-Franse LV, et al. Surgical resection of the primary tumour is associated with improved survival in patients with distant metastatic breast cancer at diagnosis[J]. Eur J Surg Oncol,2009, 35(11):1146-1151.
[12] Thomas A, Khan SA, Chrischilles EA, et al.Initial surgery and survival in stage Ⅳ breast cancer in the United States, 1988-2011[J]. JAMA Surg,2016,151(5):424-431.
[13] Choi SH, Kim JW, Choi J, et al.Locoregional treatment of the primary tumor in patients with de novo Stage Ⅳ breast cancer: a radiation oncologist's perspective[J]. Clin Breast Cancer,2017,18(2):e167-e178.
[14] Harris E, Barry M, Kell MR.Meta-analysis to determine if surgical resection of the primary tumour in the setting of stage IV breast cancer impacts on survival[J]. Ann Surg Oncol,2013,20(9):2828-2834.
[15] Badwe R, Hawaldar R, Nair N, et al.Locoregional treatment versus no treatment of the primary tumour in metastatic breast cancer: an open-label randomised controlled trial[J]. Lancet Oncol,2015,16(13):1380-1388.
[16] Fitzal F, Bjelicradisic V, Knauer M, et al. Impact of breast surgery in primary metastasized breast cancer: outcomes of the prospective randomized phase Ⅲ ABCSG-28 POSYTIVE trial[J]. Ann Surg,2018-04-24[Epub ahead of print].
[17] Soran A, Ozmen V, Ozbas S, et al.Randomized trial comparing resection of primary tumor with no surgery in stage Ⅳ breast cancer at presentation: protocol MF07-01[J]. Ann Surg Onco,2018,13(Suppl 1):1-9.
[18] Lu S, Wu J, Fang Y, et al.The impact of surgical excision of the primary tumor in stage IV breast cancer on survival: a meta-analysis[J]. Oncotarget,2018,9(14):11816-11823.
[19] Shien T, Nakamura K, Shibata T, et al.A randomized controlled trial comparing primary tumour resection plus systemic therapy with systemic therapy alone in metastatic breast cancer (PRIM-BC): Japan Clinical Oncology Group Study JCOG1017[J]. Jpn J Clin Oncol,2012,42(10):970-973.
[20] Le Scodan R, Stevens D, Brain E, et al.Breast cancer with synchronous metastases: survival impact of exclusive locoregional radiotherapy[J]. J Clin Oncol,2009,27(9):1375-1381.
[21] Mauro GP, de Andrade Carvalho H, Stuart SR, et al. Effects of locoregional radiotherapy in patients with metastatic breast cancer[J]. Breast,2016,28:73-78.
[22] Cardoso F, Senkus E, Costa A, et al.4th ESO-ESMO International Consensus Guidelines for advanced breast cancer (ABC 4)[J]. Ann Oncol,2018,29(8):1634-1657.
[23] Steinauer K, Gross MW, Huang DJ, et al.Radiotherapy in patients with distant metastatic breast cancer[J]. Ra-diat Oncol,2014,9:126.
[24] Meimarakis G, Rüttinger D, Stemmler J, et al.Prolonged overall survival after pulmonary metastasectomy in patients with breast cancer[J]. Ann Thorac Surg,2013,95(4):1170-1180.
[25] Chua TC, Saxena A, Liauw W, et al.Hepatic resection for metastatic breast cancer: a systematic review[J]. Eur J Cancer,2011,47(15):2282-2290.
[26] Nanji S, Cleary S, Ryan P, et al.Up-front hepatic resection for metastatic colorectal cancer results in favorable long-term survival[J]. Ann Surg Oncol,2013,20(1):295-304.
[27] Tasleem S, Bolger JC, Kelly ME, et al. The role of liver resection in patients with metastatic breast cancer: a systematic review examining the survival impact[J]. Ir J Med Sci,2018-02-01 [Epub ahead of print].
[28] Hong TS, Wo JY, Mcdonnell EI, et al.A single arm phase 2 study of individualized proton-based stereotactic body radiation therapy (P-SBRT) of liver metastases[J]. Int J Radiat Oncol Biol Phys,2015,93(3):S112.
[29] Scorsetti M, Comito T, Tozzi A, et al.Final results of a phase Ⅱ trial for stereotactic body radiation therapy for patients with inoperable liver metastases from colorectal cancer[J]. J Cancer Res Clin Oncol,2015,141(3):543-553.
[30] Yoshimoto M, Tada K, Nishimura S, et al.Favourable long-term results after surgical removal of lung metastases of breast cancer[J]. Breast Cancer Res Treat,2008, 110(3):485-491.
[31] Planchard D, Soria JC, Michiels S, et al.Uncertain benefit from surgery in patients with lung metastases from breast carcinoma[J]. Cancer,2004,100(1):28-35.
[32] Friedel G, Pastorino U, Ginsberg RJ, et al.Results of lung metastasectomy from breast cancer: prognostic criteria on the basis of 467 cases of the international registry of lung metastases[J]. Eur J Cardiothorac Surg,2002,22(3):335-344.
[33] Rusthoven KE, Kavanagh BD, Burri SH, et al.Multi-institutional phase Ⅰ/Ⅱ trial of stereotactic body radiation therapy for lung metastases[J]. J Clin Oncol,2009,27(10):1579-1584.
[34] Hof H, Hoess A, Oetzel D, et al.Stereotactic single-dose radiotherapy of lung metastases[J]. Strahlenther Onkol,2007,183(12):673-678.
[35] Patchell RA, Tibbs PA, Walsh JW, et al.A randomized trial of surgery in the treatment of single metastases to the brain[J]. N Engl J Med,1990,322(8):494-500.
[36] Patchell RA, Tibbs PA, Regine WF, et al.Postoperative radiotherapy in the treatment of single metastases to the brain: a randomized trial[J]. JAMA,1998,280(17):1485-1489.
[37] Vecht CJ, Haaxma-Reiche H, Noordijk EM, et al.Treatment of single brain metastasis: radiotherapy alone or combined with neurosurgery?[J]. Ann Neurol,1993,33(6):583-590.
[38] Noordijk EM, Vecht CJ, Haaxma-Reiche H, et al.The choice of treatment of single brain metastasis should be based on extracranial tumor activity and age[J]. Int J Radiat Oncol Biol Phys,1994,29(4):711-717.
[39] Brown PD, Ballman KV, Cerhan JH, et al.Postoperative stereotactic radiosurgery compared with whole brain radiotherapy for resected metastatic brain disease (NCCTG N107C/CEC·3): a multicentre, randomised, controlled, phase 3 trial[J]. Lancet Oncol,2017,18(8):1049-1060.
